Strain Data Sheet

RBRC00305

Strain Information

Image
BRC No.RBRC00305
TypeTargeted MutationCartagena
SpeciesMus musculus
Strain nameB6.129S-Tnf<tm1Ljo> Rela<tm1Yuo>/Rbrc
Former Common nameC57BL/6-Tnf<tm1Ljo> Rela<tm1Yuo>/Rbrc, TNFκB, TNF kappa B
H-2 Haplotype
ES Cell lineW9.5/D3 for TNF alpha, CCE [129/Sv] for relA
Background strainC57BL/6
Appearanceblack [a/a B/B C/C]
Strain developmentProduced by corssing relA deficient mice and TNF deficient mice strains. Neomycin cassettes were inserted into the nucleotides 3704-5364 of TNF gene and the downstream of the translation initiation codon of relA gene, respectively. RelA deficient mice were backcrossed to C57BL/6 for 10 generations, and TNF deficient mice were backcrossed to C57BL/6 for 5 generations. Then, the two mutant strains were crossed to create the TNFkB mice. Developed by Takahiro Doi at Aichi Cancer Research Center in 1997.
Strain descriptionTNF and RelA double knockout mice. TNF, tumor necrosis factor is a multifunction proinflammatory cytokine. RelA, v-rel reticuloendotheliosis viral oncogene homolog A (Avian) is one of NF-kB family relating to the development of lymphocytes, suggested to be highly sensitive to TNF cytotoxicity. Mice lacking only relA gene die between days 14 and 15 of embryogenesis due to liver cell apoptosis by endogenous TNF cytotoxicity. Meanwhile, TNF/relA double-deficient mice are viable and have normal liver. This strain is useful for studies of functions of RelA in vivo.
Colony maintenanceTNF: Homozygote x Homozygote; RelA: Heterozygote x Wild-type
References
Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality.
Doi T S, Marino M W, Takahashi T, Yoshida T, Sakakura T, Old L J, Obata Y
Proc. Natl. Acad. Sci. USA, 96, 2994-2999 (1999). 10077625

Characterization of tumor necrosis factor-deficient mice.
Marino M W, Dunn A, Grail D, Inglese M, Noguchi Y, Richards E, Jungbluth A, Wada H, Moore M, Williamson B, Basu S, Old L J
Proc. Natl. Acad. Sci. USA, 94, 8093-8098 (1997). 9223320

NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses.
Doi T S, Takahashi T, Taguchi O, Azuma T, Obata Y
J. Exp. Med., 185, 953-961 (1997). 9120401

Health Report

Examination Date / Room / Rack

Gene

Gene SymbolGene NameChr.Allele SymbolAllele NameCommon NamesPromoterDiseases Related to This Gene
Tnftumor necrosis factor17Tnftargeted mutation 1, Lioyd J Old
  • inherited susceptibility to asthma(MedGEN)

  • malaria, susceptibility to(MedGEN)

  • migraine with or without aura, susceptibility to, 1(MedGEN)
  • more 1 Diseases
  • mucocutaneous ulceration, chronic(MedGEN)
  • neoneomycin resistance gene (E. coli)17mouse phosphoglycerate kinase promoter (PGK promoter)
  • inherited susceptibility to asthma(MedGEN)

  • malaria, susceptibility to(MedGEN)

  • migraine with or without aura, susceptibility to, 1(MedGEN)
  • more 1 Diseases
  • mucocutaneous ulceration, chronic(MedGEN)
  • Relav-rel reticuloendotheliosis viral oncogene homolog A (avian)19Relatargeted mutation 1, Yuichi Obata
  • inherited susceptibility to asthma(MedGEN)

  • malaria, susceptibility to(MedGEN)

  • migraine with or without aura, susceptibility to, 1(MedGEN)
  • more 1 Diseases
  • mucocutaneous ulceration, chronic(MedGEN)
  • neoneomycin resistance gene (E. coli)19herpes simplex virus thymidine kinase promoter (HSV tk promoter)
  • inherited susceptibility to asthma(MedGEN)

  • malaria, susceptibility to(MedGEN)

  • migraine with or without aura, susceptibility to, 1(MedGEN)
  • more 1 Diseases
  • mucocutaneous ulceration, chronic(MedGEN)
  • Phenotype

    Annotation by Mammalian phenotyhpe ontology
  • abnormal Peyer's patch T cell area morphology(MP:0002392)

  • abnormal Peyer's patch follicle morphology(MP:0002389)

  • abnormal Peyer's patch germinal center morphology(MP:0002391)

  • abnormal cerebral cortex morphology(MP:0000788)

  • abnormal chemokine secretion(MP:0008722)
  • more 47 phenotypes
  • abnormal cytokine secretion(MP:0003009)

  • abnormal follicular dendritic cell physiology(MP:0008197)

  • abnormal hepatocyte morphology(MP:0000607)

  • abnormal liver morphology(MP:0000598)

  • abnormal long-term spatial reference memory(MP:0008432)

  • abnormal lung morphology(MP:0001175)

  • abnormal lymph node cell ratio(MP:0008828)

  • abnormal lymphocyte physiology(MP:0003945)

  • abnormal motor coordination/balance(MP:0001516)

  • abnormal myogenesis(MP:0000729)

  • abnormal nervous system physiology(MP:0003633)

  • abnormal neutrophil physiology(MP:0002463)

  • abnormal spleen B cell follicle morphology(MP:0008470)

  • abnormal susceptibility to infection(MP:0001793)

  • absent follicular dendritic cells(MP:0008201)

  • absent spleen germinal center(MP:0008474)

  • decreased B cell proliferation(MP:0005093)

  • decreased IgA level(MP:0001807)

  • decreased IgG level(MP:0001805)

  • decreased IgG1 level(MP:0008495)

  • decreased Peyer's patch number(MP:0008133)

  • decreased T cell proliferation(MP:0005095)

  • decreased apoptosis(MP:0006043)

  • decreased circulating tumor necrosis factor level(MP:0008554)

  • decreased double-positive T cell number(MP:0005092)

  • decreased immunoglobulin level(MP:0002460)

  • decreased skeletal muscle fiber diameter(MP:0009402)

  • decreased spleen white pulp amount(MP:0008479)

  • decreased susceptibility to autoimmune disorder(MP:0005351)

  • decreased susceptibility to bacterial infection(MP:0002411)

  • decreased susceptibility to endotoxin shock(MP:0008734)

  • impaired coordination(MP:0001405)

  • increased interferon-gamma secretion(MP:0008566)

  • increased leukocyte cell number(MP:0000218)

  • increased lymphocyte cell number(MP:0005013)

  • increased neutrophil cell number(MP:0000219)

  • increased skeletal muscle fiber number(MP:0009405)

  • increased susceptibility to bacterial infection(MP:0002412)

  • increased susceptibility to fungal infection(MP:0005399)

  • increased susceptibility to parasitic infection(MP:0005027)

  • lethality throughout fetal growth and development, complete penetrance(MP:0011099)

  • liver/biliary system phenotype(MP:0005370)

  • lung inflammation(MP:0001861)

  • lymph node hypoplasia(MP:0008101)

  • skin inflammation(MP:0004947)

  • skin lesions(MP:0001212)

  • small Peyer's patches(MP:0008135)
  • Detailed phenotype data

    Ordering Information

    Donor DNAmouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, mouse Tnf genomic DNA, herpes simplex virus thymidine kinase promoter (HSV tk promoter), mouse Rela genomic DNA
    Research applicationApoptosis Research
    Cancer Research
    Cardiovascular Research
    Developmental Biology Research
    Diabetes and Obesity Research
    Endocrine Deficiency Research
    Hematological Research
    Immunology and Inflammation Research
    Internal/Organ Research
    Neurobiology Research
    covid19_onset
    covid19_progression
    Specific Term and ConditionsIn publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Proc Natl Acad Sci USA., 96, 2994-2999 (1999). The for-profit institutions should obtain written confirmation from Ludwig Institute for Cancer Research. Ludwig Institute for Cancer Research: 1275 York Avenue, New York NY 10021, USA, FAX: 1+212-717-3100
    Any patent rights and other intellectual properties are retained by the depositor and Ludwig Institute for Cancer Research. Users should contact the depositor and Ludwig Institute for Cancer Research in the case of application for any patents with the results from these mice.
    DepositorTakahiro Doi (RIKEN)
    Strain Statusan icon for Frozen embryosFrozen embryos
    an icon for Frozen spermFrozen sperm
    Strain AvailabilityRecovered litters from cryopreserved embryos (2 to 4 months)
    Cryopreserved sperm (within 1 month)
    Cryopreserved embryos (within 1 month)
    Additional Info.Necessary documents for ordering:
    1. Order form (Japanese / English)
    2. Category I MTA: MTA for distribution with RIKEN BRC (Japanese / English)
    3. Acceptance of responsibility for living modified organism (Japanese / English)

    Genotyping protocol -PCR-
    Mouse of the Month May 2009

    BRC mice in Publications

    No Data